HSPA1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.603380E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.892000E-02
Normal-vs-Stage2
1.603250E-03
Normal-vs-Stage3
1.854000E-01
Normal-vs-Stage4
1.323380E-01
Stage1-vs-Stage2
5.122800E-03
Stage1-vs-Stage3
2.756800E-01
Stage1-vs-Stage4
1.792030E-01
Stage2-vs-Stage3
9.867000E-01
Stage2-vs-Stage4
6.577000E-01
Stage3-vs-Stage4
4.918800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.702910E-03
Normal-vs-AfricanAmerican
1.212750E-01
Normal-vs-Asian
3.689800E-01
Caucasian-vs-AfricanAmerican
4.964600E-01
Caucasian-vs-Asian
6.914000E-01
AfricanAmerican-vs-Asian
9.272000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.618700E-03
Normal-vs-Female
4.526600E-01
Male-vs-Female
9.571800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.064000E-01
Normal-vs-Age(41-60Yrs)
2.922400E-02
Normal-vs-Age(61-80Yrs)
3.883200E-03
Normal-vs-Age(81-100Yrs)
1.507780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.432200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.376070E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.527000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.277200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.383380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.004190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.894400E-01
Normal-vs-Daily Drinker
5.031500E-02
Normal-vs-Weekly Drinker
9.592100E-02
Normal-vs-Occasional Drinker
2.010000E-01
Normal-vs-Social Drinker
1.686410E-01
Non Drinker-vs-Daily Drinker
6.869200E-01
Non Drinker-vs-Weekly Drinker
3.698200E-01
Non Drinker-vs-Occasional Drinker
2.778400E-01
Non Drinker-vs-Social Drinker
9.067500E-02
Daily Drinker-vs-Weekly Drinker
4.745800E-01
Daily Drinker-vs-Occasional Drinker
6.798600E-01
Daily Drinker-vs-Social Drinker
1.759210E-01
Weekly Drinker-vs-Occasional Drinker
6.807200E-01
Weekly Drinker-vs-Social Drinker
1.760420E-01
Occasional Drinker-vs-Social Drinker
3.256100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.840240E-01
Normal-vs-Grade 2
5.900800E-01
Normal-vs-Grade 3
2.969000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.483100E-03
Grade 1-vs-Grade 3
2.628300E-02
Grade 1-vs-Grade 4
1.840240E-01
Grade 2-vs-Grade 3
8.323600E-02
Grade 2-vs-Grade 4
5.900800E-01
Grade 3-vs-Grade 4
2.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.226100E-02
Normal-vs-NonDiabetic
4.719100E-03
Diabetic-vs-NonDiabetic
9.211200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.309800E-02
Normal-vs-NoPancreatitis
4.075600E-03
Pancreatitis-vs-NoPancreatitis
3.665200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.615400E-01
Normal-vs-N1
2.216900E-03
N0-vs-N1
1.799970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.045700E-02
Normal-vs-TP53-NonMutant
6.328600E-01
TP53-Mutant-vs-TP53-NonMutant
9.757600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
